BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND PPFIBP1, L2, 8496, ENSG00000110841, hSGT2, hSgt2p AND Diagnosis
4 results:

  • 1. Incidental diagnosis of Metastatic Breast cancer in a Man With 99m Tc-PSMA SPECT/CT.
    Zárate-García CD; Cardoza-Ochoa DR; Sánchez-Vera Y; González-Díaz JI
    Clin Nucl Med; 2023 Apr; 48(4):e163-e164. PubMed ID: 36728144
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Performance of prostate Imaging Reporting and Data System Version 2.1 for diagnosis of prostate cancer: A Systematic Review and Meta-Analysis.
    Park KJ; Choi SH; Kim MH; Kim JK; Jeong IG
    J Magn Reson Imaging; 2021 Jul; 54(1):103-112. PubMed ID: 33576169
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Discovery and characterization of long intergenic non-coding RNAs (lincRNA) module biomarkers in prostate cancer: an integrative analysis of RNA-Seq data.
    Cui W; Qian Y; Zhou X; Lin Y; Jiang J; Chen J; Zhao Z; Shen B
    BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S3. PubMed ID: 26100580
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Urinary proteome analysis for prostate cancer diagnosis: cost-effective application in routine clinical practice in Germany.
    Schiffer E; Bick C; Grizelj B; Pietzker S; Schöfer W
    Int J Urol; 2012 Feb; 19(2):118-25. PubMed ID: 22103570
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.